[1] Trivedi et al. Metabolomics for the masses: The future of metabolomics in a personalized world. New Horiz Transl Med. 2017; 3(6): 294–305

[2] Sidgel TK, Gao Y, He J et al. Mining the human urine proteome for monitoring renal trans­plant injury. Kidney Int. 2016; 89:1244–52

[3] Currie et al. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy. Curr Diab Rep. 2016; 16(11): 104

[4] Wu et al. Physiological conditions can be reflected in human urine proteome and metabolome. Expert Rev Proteomics. 2015; 12(6): 623–36

[5] Zhang et al. 2015. Metabolomics for Biomarker Discovery: Moving to the Clinic. Biomed Res Int. 2015; 354671

[6] Alonso et al. Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. 2016; 14(1): 133

[7] Adamko et al. Urine metabolomic profiling of children with respiratory tract infections in the emergency department: a pilot study. BMC Infect Dis. 2016; 16(1): 439

[8] Leng et al. Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes. EBioMedicine. 2017; 18: 300–10

[9] Budde et al. Quality assurance in the pre-analytical phase of human urine samples by (1)H NMR spectroscopy. Arch Biochem Biophys. 2016; 589: 10–7

[10] Klupczyńska et al. Metabolomics in medical sciences – trends, challenges and perspectives. Acta Pol Pharm. 2015; 72(4): 629–41